Amicus Therapeutics Inc — Quarterly Financial Data (NASDAQ:FOLD) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Dividends per share —————— — Dividend yield % —————— — Payout ratio % —————— —

Amicus Therapeutics Inc

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

ニュース

バイオマリン・ファーマシューティカルのEVP、160万ドル相当の株式を売却

Canaccord raises BioMarin stock price target to $104 on earnings

Celldex Therapeutics Stock Earns 88 RS Rating

BMRN Beats on Q4 Earnings, to Withdraw Roctavian From Market

BioMarin 2025年第4四半期決算：ROCTAVIAN関連費用計上も売上高17%増

BioMarin posts mixed Q4 results, shares edge lower

Amicus' Q4 Earnings Miss, Higher Product Sales Drive Y/Y Revenues

BioMarin earnings loom with estimates falling on Voxzogo worries

BB Biotech 2025年度決算:利益660%急増も2026年は慎重見通し

Amicus earnings on deck as $4.8B BioMarin deal awaits vote

What to Expect From These Drug/Biotech Players This Earnings Season?

ベアードはライバル企業の良好な試験データにもかかわらずバイオマリンの株式評価を維持